Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI

Neuroradiology

Volumn 50, Issue 6, 2008, Pages 531-540

  Haris, Mohammad ^a   Gupta, Rakesh Kumar ^a   Singh, Anup ^b   Husain, Nuzhat ^c   Husain, Mazhar ^c   Pandey, Chandra Mohan ^a   Srivastava, Chhitij ^c   Behari, Sanjay ^a   Rathore, Ram Kishore Singh ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Blood brain permeability; Brain abscess; Brain tuberculoma; Brain tumor; DCE MRI

Indexed keywords

GADODIAMIDE; VASCULOTROPIN;

ADULT; ARTICLE; BRAIN ABSCESS; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN INFECTION; BRAIN PERFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLIOMA; GRANULOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INTRACRANIAL TUBERCULOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BLOOD-BRAIN BARRIER; BRAIN DISEASES; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 44449131471     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-008-0378-6     Document Type: Article

References (33)

1. Gupta RK, Kathuria M, Pradhan S (1999) Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 20:867-875
2. Gupta RK, Husain M, Vatsal DK, Kumar R, Chawla S, Husain N (2002) Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas. Magn Reson Imaging 20:375-381
3. Mishra AM, Gupta RK, Jaggi RS, Reddy JS, Jha DK, Husain N, Prasad KN, Behari S, Husain M (2004) Role of diffusion-weighted imaging and in vivo proton MR spectroscopy in the differential diagnosis of ring enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 28:540-547
4. Garg M, Gupta RK, Husain M, Chawla S, Chawla J, Kumar R, Rao SB, Misra MK, Prasad KN (2004) Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 230:519-527
5. Holmes TM, Petrella JR, Provenzale JM (2004) Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJNR Am J Neuroradiol 183:1247-1252
6. Chan JH, Tsui EY, Chau LF, Chow KY, Chan MS, Yuen MK, Chan TL, Cheng WK, Wong KP (2002) Discrimination of an infected brain tumor by cerebral brain abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 26:19-23
7. Batra A, Tripathi RP (2003) Perfusion magnetic resonance imaging in intracerebral parenchymal tuberculosis: preliminary findings. J Comput Assist Tomogr 27:882-888
8. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15-18
9. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
10. Machein MR, Kullmer J, Fiebich BL, Plate KH, Wamke PC (1999) Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 44:732-741
11. van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Kimpen JL, Schoeman JF (2004) Vascular endothelial growth factor and blood brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J 23:608-613
12. Abe Y, Sugisaki K, Dannenberg AM Jr (1996) Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation. J Leukoc Biol 60:692-703
13. Kielian T, Hickey WF (2000) Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol 157:647-658
14. Baldwin AC, Kielian T (2004) Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 151:24-32
15. Jackson A (2003) Imaging microvasculature structure with contrast enhanced MRI. Br J Radiol 76:159-173
16. Cha S, Lu S, Johnson G, Knopp EA (2000) Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 11:114-119
17. Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, Gazit IE, Linggood RM, Fischman AJ, Rosen BR (1995) Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 36:520-528
18. Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501-523
19. Jackson A (2004) Analysis of dynamic contrast enhanced MRI. Br J Radiol 77:154-166
20. Singh A, Haris M, Rathore D, Purwar A, Sarma MK, Bayu G, Husain N, Rathore RK, Gupta RK (2007) Quantification of physiological and hemodynamic indices using T1 dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26:871-880
21. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
22. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998) Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139-152
23. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
24. Shweiki D, Neerman M, Itin A, Keshet E (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 92:768-772
25. Black KL, Ningaraj NS (2004) Modulation of tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11:165-173
26. Chio CC, Baba T, Black KL (1992) Selective blood-tumor barrier disruption by leukotrienes. J Neurosurg 77:407-410
27. Uchida M, Chen Z, Liu Y, Black KL (2002) Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase. Neurol Res 24:739-774
28. Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nat Med 2:1174-1178
29. Maenpaa A, Kovanen PE, Paetau A, Jaaskelainen J, Timonen T (1997) Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomas. Acta Neuropathol 94:216-225
30. Badruddoja MA, Krouwer HG, Rand SD, Rebro KJ, Pathak AP, Schmainda KM (2003) Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 5:235-243
31. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746-755
32. trans) related to histologic grade in human gliomas. AJNR Am J Neuroradiol 26:2455-2465
33. Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891-899